ArticleJournal of pancreatic cancer2021

Immunotherapy Is Associated with a Survival Benefit in Patients Receiving Chemotherapy for Metastatic Pancreatic Cancer.

Jonathan J Hue et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.